# Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea

> **NCT01073631** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 543 (actual)

## Conditions studied

- Serious Fungal Infections

## Interventions

- **DRUG:** voriconazole tablet

## Key facts

- **NCT ID:** NCT01073631
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 543 (ACTUAL)
- **Last updated:** 2012-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073631, "Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01073631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*